WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

$113.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
John Wiley & Sons Inc
05 May 2022
An Introduction to Testing for Drugs of Abuse

An Introduction to Testing for Drugs of Abuse presents a distilled set of facts about the major drugs of abuse that are encountered in clinical practice. Individual chapters highlight the similarities in chemical structure, mechanism of action, and physiologic effects of each drug group, as well as their metabolism, therapeutic uses and potential for misuse or abuse. Special attention is given to the testing process, with an emphasis on interpretation of test results.

Informative and entertaining cases appear at the end of each chapter. These cases illustrate the many situations in which drug testing is performed for medical, legal and employment purposes.

Written in clear, concise language, this book provides practical guidance to pathologists, clinical chemists and technologists who are responsible for reporting and interpreting the results of drug analyses. It will be especially useful to residents and students who are learning about toxicology for the first time. Clinical practitioners – doctors, nurses, pharmacists and other health care professionals – will find the information they need to order and interpret drug tests accurately.

For more information watch the trailer here:  https://players.brightcove.net/4931690914001/B1xdbomRDl_default/index.html?videoId=6310075842112
By:  
Imprint:   John Wiley & Sons Inc
Country of Publication:   United States
Dimensions:   Height: 229mm,  Width: 152mm,  Spine: 13mm
Weight:   340g
ISBN:   9781119794059
ISBN 10:   1119794056
Pages:   208
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

About the Author William E. Schreiber is a Professor in the Department of Pathology and ­Laboratory Medicine at The University of British Columbia and Clinical Director of Chemistry at LifeLabs. Previously, he was a consultant pathologist at Vancouver General Hospital and medical director of the British Columbia Provincial Toxicology Centre. He is a past president of the American Society for Clinical Pathology.

See Also